Bought CRL, HOLX, NVO, WLP.

Some stocks have not yet participated in the current market rally or have come down from recent highs. CRL is laboratory equipment company off recent highs in the category ‘buy on the dips, sell on the rises’. HOLX, the women’s healthcare company is in the same category. NVO is a major specialty pharmaceutical company with a huge diabetes franchise in the category ‘lower risk, solid company, under the radar’. WLP, mentioned recently, is a managed care company. All have excellent earnings and reasonable growth.